Evercore Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,425
| Closed | -$282K | – | 411 |
|
|
2022
Q1 | $282K | Hold |
22,425
| – | – | 0.01% | 359 |
|
|
2021
Q4 | $261K | Hold |
22,425
| – | – | ﹤0.01% | 383 |
|
|
2021
Q3 | $293K | Hold |
22,425
| – | – | 0.01% | 368 |
|
|
2021
Q2 | $289K | Hold |
22,425
| – | – | 0.01% | 369 |
|
|
2021
Q1 | $251K | Hold |
22,425
| – | – | 0.01% | 395 |
|
|
2020
Q4 | $255K | Hold |
22,425
| – | – | 0.01% | 385 |
|
|
2020
Q3 | $202K | Hold |
22,425
| – | – | ﹤0.01% | 366 |
|
|
2020
Q2 | $231K | Hold |
22,425
| – | – | 0.01% | 343 |
|
|
2020
Q1 | $226K | Sell |
22,425
-420
| -2% | -$4.94K | 0.01% | 327 |
|
|
2019
Q4 | $304K | Buy |
22,845
+420
| +2% | +$4.63K | 0.01% | 341 |
|
|
2019
Q3 | $193K | Hold |
22,425
| – | – | 0.01% | 394 |
|
|
2019
Q2 | $245K | Sell |
22,425
-4,350
| -16% | -$48.7K | 0.01% | 365 |
|
|
2019
Q1 | $303K | Hold |
26,775
| – | – | 0.01% | 329 |
|
|
2018
Q4 | $232K | Hold |
26,775
| – | – | 0.01% | 341 |
|
|
2018
Q3 | $414K | Hold |
26,775
| – | – | 0.01% | 301 |
|
|
2018
Q2 | $429K | Hold |
26,775
| – | – | 0.01% | 282 |
|
|
2018
Q1 | $346K | Hold |
26,775
| – | – | 0.01% | 281 |
|
|
2017
Q4 | $336K | Hold |
26,775
| – | – | 0.01% | 295 |
|
|
2017
Q3 | $354K | Hold |
26,775
| – | – | 0.01% | 292 |
|
|
2017
Q2 | $423K | Hold |
26,775
| – | – | 0.02% | 276 |
|
|
2017
Q1 | $383K | Hold |
26,775
| – | – | 0.02% | 290 |
|
|
2016
Q4 | $343K | Hold |
26,775
| – | – | 0.01% | 292 |
|
|
2016
Q3 | $356K | Hold |
26,775
| – | – | 0.01% | 287 |
|
|
2016
Q2 | $293K | Hold |
26,775
| – | – | 0.01% | 303 |
|
|
2016
Q1 | $245K | Hold |
26,775
| – | – | 0.01% | 319 |
|
|
2015
Q4 | $260K | Hold |
26,775
| – | – | 0.01% | 330 |
|
|
2015
Q3 | $234K | Hold |
26,775
| – | – | 0.01% | 361 |
|
|
2015
Q2 | $271K | Hold |
26,775
| – | – | 0.01% | 375 |
|
|
2015
Q1 | $359K | Buy |
26,775
+18,704
| +232% | +$245K | 0.02% | 322 |
|
|
2014
Q4 | $103K | Hold |
8,071
| – | – | 0.01% | 461 |
|
|
2014
Q3 | $88K | Hold |
8,071
| – | – | ﹤0.01% | 531 |
|
|
2014
Q2 | $103K | Hold |
8,071
| – | – | 0.01% | 503 |
|
|
2014
Q1 | $83K | Buy |
8,071
+7,474
| +1,252% | +$84K | ﹤0.01% | 520 |
|
|
2013
Q4 | $6K | Sell |
597
-9,132
| -94% | -$82K | ﹤0.01% | 790 |
|
|
2013
Q3 | $97K | Buy |
9,729
+3,612
| +59% | +$35.4K | 0.01% | 491 |
|
|
2013
Q2 | $51K | Buy |
+6,117
| New | +$74.1K | ﹤0.01% | 567 |
|
Other funds holding IRWD
SCM
BCM
PI
CS
Evercore Wealth Management's IRWD Position: Q2 2022 in Review
Evercore Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 22,425 shares — an estimated $282K sold.
Evercore Wealth Management first reported a position in IRWD in Q2 2013 and held it in 36 quarters. The position peaked at $429K in Q2 2018. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.
- Evercore Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Evercore Wealth Management sold 22,425 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $282K.
- Evercore Wealth Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 36 quarters.
- Evercore Wealth Management's Ironwood Pharmaceuticals position peaked at $429K in Q2 2018.
- 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.
Based on Evercore Wealth Management's 13F filing for Q2 2022, filed 15 Aug 2022.